Obtenez 3 mois à 0,99 $/mois + 20 $ de crédit Audible

OFFRE D'UNE DURÉE LIMITÉE
Page de couverture de VerifiedRx

VerifiedRx

VerifiedRx

Auteur(s): Vizient Center for Pharmacy Practice Excellence
Écouter gratuitement

À propos de cet audio

 Delivering short doses of insight for hospitals’ frontline pharmacy professionals, the Vizient pharmacy team brings together experts to verify best practices for navigating today’s pharmacy practice challenges and accelerating career growth. It’s a prescription for success, delivered by the Vizient Center for Pharmacy Practice Excellence.Copyright 2025 All rights reserved. Développement commercial et entrepreneuriat Entrepreneurship Gestion et leadership Hygiène et mode de vie sain Science Troubles et maladies Économie
Épisodes
  • Beyond the Formulary: Evolving Enterprise P&T Committees

    Beyond the Formulary: Evolving Enterprise P&T Committees
    Nov 11 2025

    Pharmacy and Therapeutics (P&T) committees historically operated at the individual hospital level but have evolved into enterprise-wide governance programs due to health system expansion, unprecedented clinical and financial complexity of care, and the emergence of high impact and novel therapeutics.

    To address this, the Vizient Center for Pharmacy Practice Excellence convened an expert panel that concluded health system enterprise P&T committees are uniquely positioned to balance clinical value with financial stewardship and minimize practice variation. They issued best practice considerations representing a dynamic framework designed to evolve alongside emerging therapies, evolving technologies, and the ongoing transformation of health systems.

    Joining us today are two members of the expert panel. We have Connor Hanrahan, AVP, enterprise pharmacy services, medication outcomes and stewardship with Intermountain Health and Prabashni Reddy, who at the time of the panel was the executive director of medication use and policy at Mass General Brigham.

    Guest speakers:

    Prabashni Reddy, RPh, PharmD, MMedSc (former) Executive Director of Medication Use and Policy

    Mass General Brigham

    Connor Hanrahan, PharmD, MHA, MS, BCPS, CPHQ AVP, Medication Policy, Outcomes, and Stewardship

    Intermountain Health, Enterprise Pharmacy Services

    Host:

    Kerry Schwarz, PharmD, MPH 

    Senior Clinical Manager, Evidence-Based Medicine and Outcomes

    Center for Pharmacy Practice Excellence (CPPE)

    Show Notes:

    [01:02-03:38] The value Prabashni and Conor saw in joining the expert panel

    [03:39-05:33] What Prabashni and Conor learned from interactions during the expert panel

    [05:34-10:55] Intriguing actionable enterprise P&T program insights panelists brought to the table that listeners can use

    [10:56-14:01] Use of criteria and principles to create successful and broadly applicable best practices

    [14:56-16:00] How our listeners can put this panel's best practices into action

    VerifiedRx Listener Feedback Survey:

    We would love to hear from you - Please click here

    Subscribe Today!

    Apple Podcasts

    Spotify

    YouTube

    RSS Feed
    Voir plus Voir moins
    17 min
  • Challenges with AI in Pharmacy

    Challenges with AI in Pharmacy
    Oct 28 2025

    Artificial intelligence, or, AI is on everyone's minds, and we're all still figuring out how to trust it, teach it, and use it responsibly. Today we take a deep dive into how AI is affecting the education of current and future pharmacy students. With us is Jennifer Trujillo, associate Dean for education and professor in the Department of Clinical Pharmacy at the Skaggs School of Pharmacy and Pharmaceutical Sciences on the University of Colorado Anschutz Medical Campus in Aurora, Colorado, and Logan Tinsen, the clinical pharmacy manager and residency program director at Benefis Hospital in Great Falls, Montana.

    Guest speakers:

    Jennifer Trujillo, PharmD, BCPS, CDCES, BC-ADM Associate Dean for Education

    Professor, Department of Clinical Pharmacy

    Skaggs School of Pharmacy and Pharmaceutical Sciences

    University of Colorado Anschutz Medical Campus

    Logan Tinsen, PharmD, FMPA Clinical Pharmacy Manager and Residency Program Director Benefits Hospitals

    Host: 

    Kerry Schwarz, PharmD, MPH 

    Senior Clinical Manager, Evidence-Based Medicine and Outcomes

    Center for Pharmacy Practice Excellence (CPPE)

    Show Notes:

    [01:02-03:45] Challenges with AI in pharmacy education

    [03:46-05:59] The AI adoption spectrum: Pitfalls of extremes between full and limited adoption

    [06:00-11:18] Approaches to pharmacy education in the early stages of AI

    [11:19-14:55] Guardrails and safeguards

    [14:56-16:29] Key takeaways about AI right now for pharmacy educators

    VerifiedRx Listener Feedback Survey:

    We would love to hear from you - Please click here

    Subscribe Today!

    Apple Podcasts

    Spotify

    YouTube

    RSS Feed
    Voir plus Voir moins
    17 min
  • Inside the Clean Room - Safely Handling Cell & Gene Therapies

    Inside the Clean Room - Safely Handling Cell & Gene Therapies
    Oct 14 2025
    From CAR-T therapies to viral vectors, cell and gene treatments are redefining the boundaries of pharmacy practice—but with innovation comes complexity. Host Carolyn Liptak welcomes Dr. Mark Wiencek, Principal Microbiologist with the Technical Services Group at Contec, and Dr. Amanda Frick, Senior Clinical Manager of Market Intelligence at Vizient, to break down the challenges of compounding these advanced therapies. Listen in as they discuss real-world risk assessments, biosafety considerations, and how hospital pharmacies can safely manage these groundbreaking yet high-risk treatments. Guest speakers: Mark Wiencek, PhD Principal Microbiologist, Technical Services Group Contec Amanda Frick, PharmD, BCPS Senior Clinical Manager, Market Intelligence Vizient Host: Carolyn Liptak, MBA, RPh Pharmacy Executive Director Vizient Show Notes: [01:02-01:51] Mark shares his background and experience in microbiology [01:52-04:04] Overview of the types of cell and gene therapies (CGT) currently used in clinical practice [04:05-05:14] Which CGT therapies are most applicable to pharmacy compounding and why [05:15-10:29] Things not on the NIOSH list and the risks [10:30-12:03] Evaluating whether viral vectors can penetrate intact skin and the true occupational exposure risks [12:04-13:18] If hazards are not defined by the NIOSH list, how should these CGT hazards be classified [13:19-15:03] Determining the safest environment for compounding CGT therapies [15:04-20:14] Best practices for decontamination, disinfection, and viral vector handling [20:15-20:59] Do you need a dedicated biosafety cabinet for CGT therapies [21:00-22:55] Recommended resources for further learning Links | Resources: Blind and colleagues (Nationwide): Click hereWang and colleagues (Stanford): Click hereCONTEC HEALTHCARE WEBINAR Using Bugs as Drugs: Compounding Viral Vectors in Cell & Gene Therapy for Hospital Pharmacies, Mark Wiencek, May 13, 2025: Click hereBlind, J.E., Ghosh, S., Niese, T.D., Gardner, J.C., Stack-Simone, S., Dean, A. and Washam, M., 2024. A comprehensive literature scoping review of infection prevention and control methods for viral-mediated gene therapies. Antimicrobial Stewardship & Healthcare Epidemiology, 4(1), p.e15. Click hereDeramoudt, L., Pinturaud, M., Bouquet, P., Goffard, A., Simon, N. and Odou, P., 2024. Method for the detection and quantification of viral contamination during the preparation of gene therapy drugs in a hospital pharmacy. Occupational and Environmental Medicine, 81(12), pp.615-621. Click hereKorte, J., Mienert, J., Hennigs, J.K. and Körbelin, J., 2021. Inactivation of adeno-associated viral vectors by oxidant-based disinfectants. Human Gene Therapy, 32(13-14), pp.771-781. Click here (abstract only; full article available for purchase)Martino, J.G., McConnell, K., Greathouse, L., Rosario, B.D. and Jaskowiak, J.M., 2024. Cellular therapy site-preparedness: Inpatient pharmacy implementation at a large academic medical center. Journal of Oncology Pharmacy Practice, 30(8), pp.1442-1449. Click herePenzien, C., 2023. Safe handling of BioSafety drugs and live virus vaccines. Pharm Purch Prod, 20(4), p.12. Click herePetrich, J., Marchese, D., Jenkins, C., Storey, M. and Blind, J., 2020. Gene replacement therapy: a primer for the health-system pharmacist. Journal of Pharmacy Practice, 33(6), pp.846-855. Click hereWang, A., Ngo, Z., Yu, S.J. and MacDonald, E.A., 2025. Implementing standard practices in the safe handling of gene therapy and biohazardous drugs in a health-system setting. American Journal of Health-System Pharmacy, p.zxaf026. Click here VerifiedRx Listener Feedback Survey: We would love to hear from you - Please click here Subscribe Today! Apple Podcasts Spotify YouTube RSS Feed
    Voir plus Voir moins
    24 min
Pas encore de commentaire